Mengying Ke

573 total citations
16 papers, 252 citations indexed

About

Mengying Ke is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Mengying Ke has authored 16 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Hematology and 3 papers in Oncology. Recurrent topics in Mengying Ke's work include Metabolomics and Mass Spectrometry Studies (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Salivary Gland Disorders and Functions (3 papers). Mengying Ke is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Salivary Gland Disorders and Functions (3 papers). Mengying Ke collaborates with scholars based in China and Hong Kong. Mengying Ke's co-authors include Shijia Liu, Jiawei Lu, Ye Yang, Chunyan Gu, Wenjun Chen, Zhendong Deng, Yanyan Zhou, Hua Li, Lu Lü and Zhangzhang Lan and has published in prestigious journals such as Frontiers in Immunology, Advanced Science and Signal Transduction and Targeted Therapy.

In The Last Decade

Mengying Ke

15 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mengying Ke China	10	137	51	46	33	29	16	252
Juliana Cazarin Brazil	13	180 1.3×	94 1.8×	68 1.5×	68 2.1×	29 1.0×	19	440
Pinning Feng China	14	138 1.0×	61 1.2×	16 0.3×	42 1.3×	22 0.8×	35	383
Huimin Ding China	10	178 1.3×	66 1.3×	55 1.2×	36 1.1×	7 0.2×	18	282
Jinglan Ma China	5	147 1.1×	62 1.2×	74 1.6×	43 1.3×	11 0.4×	6	340
Michael W. Bolt United States	9	162 1.2×	24 0.5×	17 0.4×	42 1.3×	18 0.6×	16	419
Jolanta Krauze Poland	11	73 0.5×	27 0.5×	19 0.4×	28 0.8×	31 1.1×	43	323
Joseph R. Day United States	11	204 1.5×	66 1.3×	20 0.4×	59 1.8×	23 0.8×	11	424
P.L. Capecchi Italy	9	113 0.8×	20 0.4×	50 1.1×	10 0.3×	25 0.9×	21	272
Shunling Yuan China	7	169 1.2×	60 1.2×	8 0.2×	42 1.3×	19 0.7×	10	329

Countries citing papers authored by Mengying Ke

Since Specialization

Citations

This map shows the geographic impact of Mengying Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengying Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengying Ke more than expected).

Fields of papers citing papers by Mengying Ke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengying Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengying Ke. The network helps show where Mengying Ke may publish in the future.

Co-authorship network of co-authors of Mengying Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Mengying Ke. A scholar is included among the top collaborators of Mengying Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengying Ke. Mengying Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wang, Ling, Jie Min, Jinjun Qian, et al.. (2025). SAE1 promotes tumor cell malignancy via SUMOylation and liquid–liquid phase separation facilitated nuclear export of p27. Acta Pharmaceutica Sinica B. 15(4). 1991–2007. 1 indexed citations

Ke, Mengying, et al.. (2025). B4GALT3 as a Key Glycosyltransferase Gene in Multiple Myeloma Progression: Insights From Bioinformatics, Machine Learning, and Experimental Validation. Molecular Carcinogenesis. 64(10). 1595–1608.

Wei, Rongfang, Hongjie Wu, Xin Liu, et al.. (2023). Inhibition of VCP modulates NF-κB signaling pathway to suppress multiple myeloma cell proliferation and osteoclast differentiation. Aging. 15(16). 8220–8236. 3 indexed citations

Tang, Chao, Mengying Ke, Xichao Yu, et al.. (2023). GART Functions as a Novel Methyltransferase in the RUVBL1/β‐Catenin Signaling Pathway to Promote Tumor Stemness in Colorectal Cancer. Advanced Science. 10(25). e2301264–e2301264. 18 indexed citations

Liu, Huanhuan, et al.. (2022). Untargeted serum metabolomics reveals specific metabolite abnormalities in patients with Crohn's disease. Frontiers in Medicine. 9. 814839–814839. 12 indexed citations

Li, Rui, Mengying Ke, Zhendong Deng, et al.. (2022). G6PD promotes cell proliferation and dexamethasone resistance in multiple myeloma via increasing anti-oxidant production and activating Wnt/β-catenin pathway. Experimental Hematology and Oncology. 11(1). 77–77. 17 indexed citations

Xu, Tingting, Xiaoyan Xu, Lu Zhang, et al.. (2021). Lipidomics Reveals Serum Specific Lipid Alterations in Diabetic Nephropathy. Frontiers in Endocrinology. 12. 781417–781417. 21 indexed citations

Tang, Xiaozhu, Mengjie Guo, Zhendong Deng, et al.. (2021). BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability. Signal Transduction and Targeted Therapy. 6(1). 361–361. 39 indexed citations

Ke, Mengying, Jinjun Qian, Xinying Li, et al.. (2021). Acupuncture Synergized With Bortezomib Improves Survival of Multiple Myeloma Mice via Decreasing Metabolic Ornithine. Frontiers in Oncology. 11. 779562–779562. 4 indexed citations

10.

Luan, Hemi, Hua Li, Zi Wang, et al.. (2021). Serum metabolomic and lipidomic profiling identifies diagnostic biomarkers for seropositive and seronegative rheumatoid arthritis patients. Journal of Translational Medicine. 19(1). 500–500. 53 indexed citations

11.

Xu, Tingting, Jiawei Lu, Jinjun Shan, et al.. (2021). Untargeted serum metabolomics and potential biomarkers for Sjögren's syndrome. Clinical and Experimental Rheumatology. 39(6). 23–29. 16 indexed citations

12.

Liu, Shijia, Huanhuan Liu, Tingting Xu, et al.. (2021). Serum lipidomics reveals distinct metabolic profiles for asymptomatic hyperuricemic and gout patients. Lara D. Veeken. 61(6). 2644–2651. 14 indexed citations

13.

Xu, Tingting, Jiawei Lu, Jinjun Shan, et al.. (2021). Untargeted serum metabolomics and potential biomarkers for Sjögren's syndrome.. Clinical and Experimental Rheumatology. 39 Suppl 133(6). 23–29. 8 indexed citations

14.

Zhou, Guisheng, Jiawei Lu, Tingting Xu, et al.. (2021). Clinical lipidomics analysis reveals biomarkers of lipid peroxidation in serum from patients with rheumatoid arthritis. Microchemical Journal. 169. 106607–106607. 7 indexed citations

15.

Liu, Shijia, Lu Lu, Jiawei Lu, et al.. (2020). Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis. Frontiers in Immunology. 11. 579228–579228. 27 indexed citations

16.

Lu, Jiawei, Yan Lu, Wei Ji, et al.. (2020). Untargeted lipidomics reveals specific lipid abnormalities in Sjögren’s syndrome. Lara D. Veeken. 60(3). 1252–1259. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact